Literature DB >> 3474420

Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

E Paez, S Dallo, M Esteban.   

Abstract

To investigate the genetic stability of vaccinia virus DNA, we have tested whether alterations occurred in the polypeptide composition of this complex virus during persistent infections. We found that variants isolated at various passages in Friend erythroleukemia cells persistently infected with vaccinia virus contained, in addition to an 8-megadalton (MDa) deletion on the left terminus of the viral genome, major alterations in the sizes of three structural proteins with molecular masses of about 39, 21, and 14 kDa. Alterations in isoelectric points were also observed in proteins of 48, 27, and 14 kDa. The 14-kDa protein is part of the virus envelope, and the variants increased the size of this protein from 0.5 to 3 kDa with increasing passage number. Alteration in size of the 14-kDa protein is a dominant trait since it appeared in the whole virus population by passage 48. With more passages, some variants were found to increase or decrease the size of a 39-kDa core protein by about 2 kDa and to decrease the size of an envelope protein of 21 kDa by about 2 kDa. These three proteins were immunogenic in mice and elicited a strong host immune response. Major alterations in the sizes of these proteins were prevented by continuous treatment of the persistently infected cultures with interferon. However, after interferon was removed, protein modifications appeared with increasing passage number. Generation of the 8-MDa deletion and alterations in the size of the 14-kDa protein correlated with a marked decrease in virulence of these variants. Our findings suggest that during virus persistence, specific mutations are introduced in the vaccinia virus genome that lead to protein alterations and to highly attenuated viruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474420      PMCID: PMC255716          DOI: 10.1128/JVI.61.8.2642-2647.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Conservation and variation in Orthopoxvirus genome structure.

Authors:  M Mackett; L C Archard
Journal:  J Gen Virol       Date:  1979-12       Impact factor: 3.891

2.  Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells.

Authors:  W T Ruyechan; L S Morse; D M Knipe; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

3.  Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.

Authors:  K Essani; S Dales
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

4.  Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.

Authors:  Y Ichihashi; S Dales
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

5.  Inhibitory effect of interferon on the genetic and oncogenic transformation by viral and cellular genes.

Authors:  M Perucho; M Esteban
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

6.  Interferon inhibits transformation of mouse cells by exogenous cellular or viral genes.

Authors:  M F Dubois; M Vignal; M Le Cunff; C Chany
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

7.  Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system.

Authors:  E Paez; M Esteban
Journal:  Virology       Date:  1984-04-15       Impact factor: 3.616

8.  Analysis of replicating vaccinia DNA in interferon-treated, virus-infected cells.

Authors:  M Esteban
Journal:  J Interferon Res       Date:  1984

9.  Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA.

Authors:  E Paez; S Dallo; M Esteban
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

10.  Role of prostaglandins and non-steroid anti-inflammatory drugs in the pathogenicity of vaccinia virus.

Authors:  G Zavagno; B Jaffe; M Esteban
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

View more
  11 in total

1.  Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein.

Authors:  J F Rodriguez; M Esteban
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants.

Authors:  J F Rodriguez; M Esteban
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses.

Authors:  D Rodriguez; J R Rodriguez; J F Rodriguez; D Trauber; M Esteban
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus.

Authors:  B Sodeik; S Cudmore; M Ericsson; M Esteban; E G Niles; G Griffiths
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

5.  A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate.

Authors:  C S Chung; J C Hsiao; Y S Chang; W Chang
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells.

Authors:  J C Hsiao; C S Chung; W Chang
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Eva Pérez-Jiménez; Juan Carlos Oliveros; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

8.  Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals.

Authors:  J F Rodriguez; D Rodriguez; J R Rodriguez; E B McGowan; M Esteban
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  A vaccinia virus core protein, p39, is membrane associated.

Authors:  S Cudmore; R Blasco; R Vincentelli; M Esteban; B Sodeik; G Griffiths; J Krijnse Locker
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  A single point mutation of Ala-25 to Asp in the 14,000-Mr envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus.

Authors:  S C Gong; C F Lai; S Dallo; M Esteban
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.